首页> 美国卫生研究院文献>Pharmaceuticals >On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study
【2h】

On the Absolute Stereochemistry of Tolterodine: A Circular Dichroism Study

机译:托特罗定的绝对立体化学:圆二色性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tolterodine (>1) is a potent muscarinic receptor antagonist used in the treatment of overactive urinary bladder (OAB) syndrome. Tolterodine is chiral and it was patented, and is currently marketed, as the l-tartrate salt of the (R)-enantiomer. However, the existing literature does not offer an ultimate proof of a stereoselective mode of action of >1. A second open stereochemical issue concerns the absolute configuration (AC) of >1. Neither the original patents nor subsequent studies have established the AC of >1 in an unambiguous way, although the AC of the l-tartrate salt of >1 was assigned by X-ray diffractometry. Finally, neither electronic nor vibrational circular dichroism (ECD and VCD) spectra of >1 are reported so far. We performed a thorough ECD/VCD study of >1 in different solvents and at variable temperatures. Solvent and temperature dependence highlighted the existence of moderate flexibility which was confirmed by molecular modelling. ECD calculations with time-dependent density functional theory (TDDFT) accurately reproduced the experimental spectra and allowed us to confirm the AC of >1 in an independent way.
机译:托特罗定(> 1 )是一种有效的毒蕈碱受体拮抗剂,用于治疗膀胱过度活动症(OAB)综合征。托特罗定是手性的,它是(R)-对映异构体的酒石酸I-酒石酸盐,目前已获得专利。但是,现有文献并未提供> 1 的立体选择作用模式的最终证据。第二个开放的立体化学问题涉及> 1 的绝对配置(AC)。尽管X射线衍射法确定了> 1 的L-酒石酸盐的AC,但原始专利或后续研究都没有明确地确定> 1 的AC。 。最后,到目前为止,尚未报道> 1 的电子或振动圆二色性(ECD和VCD)光谱。我们在不同溶剂和不同温度下对> 1 进行了详尽的ECD / VCD研究。溶剂和温度依赖性突出了中等柔韧性的存在,这已通过分子建模得到证实。使用随时间变化的密度泛函理论(TDDFT)进行的ECD计算准确地再现了实验光谱,并使我们能够独立地确定> 1 的交流电。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号